10-Q Filing

APPLIED BIOSCIENCES CORP. CIK: 1607549 Q1 2015

Filing Information

Form Type	10-Q
Accession Number	`0001477932-15-005434`
Period End Date	20150630
Filing Date	20150819
Fiscal Year	2015
Fiscal Period	Q1
XBRL Instance	fift-20150630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 34 Income Statement 12 Cash Flow Statement 24

Balance Sheet 34 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`Cash`	$5.00K	USD	Point-in-time
Cash	`Cash`	-	USD	Point-in-time
Cash	`Cash`	$3.10K	USD	Point-in-time
Cash	`Cash`	-	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	2.59B	shares	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	-	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	-	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	100.04M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	2.59B	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	100.04M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.28K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.07K	USD	Point-in-time
Due to related party	`DueToRelatedPartiesCurrent`	$14.13K	USD	Point-in-time
Due to related party	`DueToRelatedPartiesCurrent`	$11.42K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$13.49K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$19.41K	USD	Point-in-time
Common stock Authorized 200,000,000 shares of common stock, $0.001 par value, Issued and outstanding 100,043,412 and 2,590,000,000 shares of common stock (Refer Note 3)	`CommonStockValue`	$2.59M	USD	Point-in-time
Common stock Authorized 200,000,000 shares of common stock, $0.001 par value, Issued and outstanding 100,043,412 and 2,590,000,000 shares of common stock (Refer Note 3)	`CommonStockValue`	$100.04K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$-91.95K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$-2.58M	USD	Point-in-time
Stock subscriptions receivable	`StockSubscriptionsReceivable`	$-2.98K	USD	Point-in-time
Stock subscriptions receivable	`StockSubscriptionsReceivable`	-	USD	Point-in-time
Common stock subscribed	`CommonStockSharesSubscriptions`	$2.98K	USD	Point-in-time
Common stock subscribed	`CommonStockSharesSubscriptions`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-27.50K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-18.49K	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIT	`StockholdersEquity`	$-19.41K	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIT	`StockholdersEquity`	$-13.49K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	-	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	-	USD	Point-in-time

Income Statement 12 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`Revenues`	-	USD	1 Quarter
REVENUE	`Revenues`	-	USD	1 Quarter
Office and general	`GeneralAndAdministrativeExpense`	$9.01K	USD	1 Quarter
Office and general	`GeneralAndAdministrativeExpense`	$5.90K	USD	1 Quarter
TOTAL EXPENSES	`OperatingExpenses`	$9.01K	USD	1 Quarter
TOTAL EXPENSES	`OperatingExpenses`	$5.90K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-9.01K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-5.90K	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
WEIGHTED AVERAGE NUMBER OF BASIC COMMON SHARES OUTSTANDING - BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	737.73M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF BASIC COMMON SHARES OUTSTANDING - BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.59B	shares	1 Quarter

Cash Flow Statement 24 line items

Line Item	Tag	Value	Unit	Period
Net loss for the period	`NetIncomeLoss`	$-9.01K	USD	1 Quarter
Net loss for the period	`NetIncomeLoss`	$-5.90K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.21K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	-	USD	1 Quarter
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-5.80K	USD	1 Quarter
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-5.90K	USD	1 Quarter
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Proceeds on sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds on sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$3.09K	USD	1 Quarter
Proceeds from related parties	`ProceedsFromRelatedPartyDebt`	$4.00K	USD	1 Quarter
Proceeds from related parties	`ProceedsFromRelatedPartyDebt`	$2.71K	USD	1 Quarter
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$5.80K	USD	1 Quarter
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$4.00K	USD	1 Quarter
NET DECREASE IN CASH	`CashPeriodIncreaseDecrease`	$-1.90K	USD	1 Quarter
NET DECREASE IN CASH	`CashPeriodIncreaseDecrease`	-	USD	1 Quarter
CASH, BEGINNING OF PERIOD	`Cash`	$5.00K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`Cash`	-	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`Cash`	$3.10K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`Cash`	-	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	$5.00K	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	-	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	$3.10K	USD	Point-in-time
CASH, END OF PERIOD	`Cash`	-	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.